Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Glioblastoma Multiforme”

505 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 505 results

Testing effectiveness (Phase 2)Ended earlyNCT00238277
What this trial is testing

Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)UnknownNCT00394628
What this trial is testing

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Novacea 60
Early research (Phase 1)Study completedNCT03452930
What this trial is testing

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaMGMT-Unmethylated Glioblastoma
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04959500
What this trial is testing

Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Sun Yat-sen University 150
Testing effectiveness (Phase 2)Study completedNCT03174197
What this trial is testing

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)UnknownNCT02663440
What this trial is testing

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Zhejiang Cancer Hospital 41
Testing effectiveness (Phase 2)Ended earlyNCT02227576
What this trial is testing

Prevention of Thrombocytopenia in Glioblastoma Patients

Who this might be right for
ThrombocytopeniaGlioblastoma
University Hospital, Lille 20
Early research (Phase 1)Study completedNCT01119599
What this trial is testing

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Acoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Ended earlyNCT02664363
What this trial is testing

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Daniel Landi 3
Early research (Phase 1)Study completedNCT03726515
What this trial is testing

CART-EGFRvIII + Pembrolizumab in GBM

Who this might be right for
Glioblastoma
University of Pennsylvania 7
Large-scale testing (Phase 3)Study completedNCT00943826
What this trial is testing

Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Hoffmann-La Roche 921
Early research (Phase 1)Study completedNCT03696355
What this trial is testing

Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00006355
What this trial is testing

Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT03139916
What this trial is testing

Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Massachusetts General Hospital 36
Early research (Phase 1)Study completedNCT02378532
What this trial is testing

The Addition of Chloroquine to Chemoradiation for Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Maastricht Radiation Oncology 13
Not applicableUnknownNCT05515133
What this trial is testing

Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma
Henan Provincial People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02805179
What this trial is testing

High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Who this might be right for
Glioma
University of Michigan Rogel Cancer Center 26
Early research (Phase 1)Study completedNCT06665724
What this trial is testing

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Who this might be right for
Anaplastic Astrocytoma (AA)Anaplastic Oligodendroglioma (AO)Glioblastoma (GBM)
Universität Münster 16
Testing effectiveness (Phase 2)Study completedNCT07120620
What this trial is testing

PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme (GBM)
Sied Kebir 33
Next Page